Join
Live feed
·
PRReleasevia Quantisnow
Nexentis Technologies Inc. logo

Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign

ByQuantisnow·Wall Street's wire, on your screen.
NXTS· Nexentis Technologies Inc.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NXTS (Nexentis Technologies Inc.) and more on Quantisnow.